Close Menu

NEW YORK — Fujifilm has partnered with Axcelead Drug Discovery Partners to offer human induced pluripotent stem cell (iPSC)-based drug discovery services, the Japanese companies said today.

Under the terms of the deal, the firms will offer iPCSs and iPCS-derived cells from Fujifilm subsidiary Fujifilm Cellular Dynamics with Axcelead's drug discovery services, as well as customized drug evaluation and toxicity testing methods.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.

Aug
29
Sponsored by
PerkinElmer

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.